Pradaxa (dabigatran) is a blood thinner drug prescribed for prevention of strokes with patients who suffer from atrial fibrillation. With atrial fibrillation, part of the heart does not beat the way it should. This could possibly cause blood clots to form, which could increase your risk of a stroke.
Pradaxa also treats blood clots in the veins of your legs (deep vein thrombosis) or lungs (pulmonary embolism) and it could reduce the risk of them happening again. However, the drug has also been used for many other “off-label” purposes.
During the first three months the drug was on the market, the FDA received 307 reports of Pradaxa problems causing internal bleeds and other complications, particularly among older users.
There have been more than 260 deaths related to Pradaxa internal bleeding, just in the first year the drug was on the market.
Many critics have questioned the tactics used by the company to gain FDA approval of Pradaxa, and some have even suggested that the drug be recalled.
Lawsuits over Pradaxa allege the warnings on the drug are inadequate. Thousands of individuals suffer from hemorrhages and bleeds on Pradaxa. Individuals in the USA who have experience these problems may be eligible to pursue a lawsuit, and we here at the Law Office Of Bobby Garcia are here to help. Contact us today for more info.